Gallup estimates roughly 40 million Americans are taking a GLP-1 medication. Those patients didn’t all stop. Many moved to compounded or gray-market versions, paid cash, and quietly walked out of the system that used to keep an eye on them.

Insurers didn’t stop covering lab work. But when patients leave the insured pathway for their medication, the prescribing physician, the follow-up visits, and the lab orders tend to leave with it. The drug stays. The oversight goes.

And long-term GLP-1 use deserves oversight. These are good medications. They are not vitamins.

Weight-loss drug side effects: Who’s checking your labs? – https://kevinmd.com/2026/11/weight-loss-drug-side-effects-whos-checking-your-labs.html

Yikes.